Back to dashboard
All PlansCoverageMedium impact

Newsletter Vol. 11, No. 79

New Jersey Medicaid·NJ · Pulmonology, Allergy & Immunology, Family Medicine +2 more·Provider Notice
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply

Summary

New policy addresses concurrent usage restrictions for respiratory medications Advair with Serevent or Advair with Flovent. This likely impacts billing and prior authorization requirements for patients prescribed these overlapping respiratory medications.

Action Required

Action needed
Immediately: Review the full policy document at the provided URL to understand specific concurrent usage restrictions. Update prior authorization workflows to flag potential concurrent usage of Advair with Serevent or Advair with Flovent. Train billing staff to identify these medication combinations during claim review.